Earnings Call · Q1 FY2022·2022-05-05

Q1 22EPS -16.67%·Rev n/aQ4 21EPS +2.56%·Rev n/aQ3 21EPS +4.29%·Rev n/aQ2 21EPS 0.00%·Rev n/a⚠ consensus missing

Royalty Pharma plc RPRX

George Grofik — Senior Vice President, Head of Investor Relations and Communications

Terry Coyne — Chief Executive Officer

−5.6%1d on move date−2.1% vs SPY3d−13.1%5d−11.3%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RPRX calls or request research access.

More RPRX calls Browse calls Request research access